Drugs / 99mTc-HFAPI
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05859763 | Dec 2021 → Jul 2023 | pulmonary fibrosis | Peking Union Medical College Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 99mTc-HFAPI | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05859763 ↗ |
| Modality | Diagnostic / imaging agent | “99mTc labeled FAPI tracer (99mTc-HFAPI)” NCT05859763 ↗ |
| Route | Subcutaneous | “subcutaneously injected with 99mTc-HFAPI” NCT05859763 ↗ |